Marine Macrolides with Antibacterial and/or Antifungal Activity

• Published in: Marine drugs 2019-04, Vol.17 (4), p.241
• Main Author: Karpiński, Tomasz M
• Format: Article
• Language: English
• Subjects: Algae; Analogs; antibacterial; antibiotic; Antibiotics; antifungal; Antifungal activity; antimicrobial; Antimicrobial agents; Bacteria; Bioactive compounds; Cyanobacteria; Cytotoxicity; Drug resistance; E coli; Fungi; Fungicides; macrolide; marine; Marine invertebrates; Marine organisms; Microorganisms; Motility; Multidrug resistant organisms; Pathogens; Review; Salmonella; Staphylococcus infections; Streptococcus infections; Yeast
• ISSN: 1660-3397; 1660-3397
• DOI: 10.3390/md17040241

Currently, the increasing resistance of microorganisms to antibiotics is a serious problem. Marine organisms are the source of thousands of substances, which also have antibacterial and antifungal effects. Among them, marine macrolides are significant. In this review, the antibacterial and/or antifungal activities of 34 groups of marine macrolides are presented. Exemplary groups are chalcomycins, curvulides, halichondramides, lobophorins, macrolactins, modiolides, scytophycins, spongistatins, or zearalanones. In the paper, 74 antibiotics or their analog sets, among which 29 with antifungal activity, 25 that are antibacterial, and 20 that are both antifungal and antibacterial are summarized. Also, 36 macrolides or their sets are produced by bacteria, 18 by fungi, ten by sponges, seven by algae, two by porifera, and one by nudibranch. Moreover, the chemical structures of representatives from each of the 34 groups of these antibiotics are presented. To summarize, marine organisms are rich in natural macrolides. Some of these may be used in the future in the treatment of bacterial and fungal infections. Marine macrolides can also be potential drugs applicable against pathogens resistant to currently known antibiotics.